Venlafaxine 50 mg Immediate Release Tablets — Generic For Effexor — Alembic

Medication Summary

Medication Summary: This section summarizes DailyMed drug label information to make the label easier to understand. It is not a substitute for the official label, pharmacist counseling, prescriber instructions, or medical advice.

Overview

Venlafaxine tablets are a prescription antidepressant used to treat major depressive disorder in adults. The label says the medicine was shown to be effective in controlled trials and that long-term use should be re-evaluated periodically by a prescriber.

The label warns that antidepressants can increase the risk of suicidal thinking and behavior in children, adolescents, and young adults, and that patients of all ages should be monitored for worsening depression, suicidality, or unusual behavior changes. Venlafaxine tablets are not approved for use in pediatric patients.

The label also warns about serotonin syndrome, sustained increases in blood pressure, angle-closure glaucoma risk in people with narrow angles, and symptoms that can happen when the medicine is stopped too quickly. Venlafaxine should not be used with certain MAO inhibitors, and the label advises gradual dose reduction when stopping whenever possible.

Storage Information

protection, if needed, may be indicated if performed soon after ingestion or in symptomatic patients. Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature] in a dry place. Dispense in a well-closed container as defined in the USP. store venlafaxine tablets? • Store venlafaxine tablets at room temperature between 68°F and 77°F (20°C to 25°C).

Key Counseling Points

• Take venlafaxine exactly as prescribed.
• Do not use venlafaxine with MAO inhibitors, and do not start it if you are taking linezolid or intravenous methylene blue.
• Watch for worsening depression, suicidal thoughts, unusual behavior changes, agitation, irritability, or insomnia, especially early in treatment or when the dose changes.
• Get medical help right away if symptoms of serotonin syndrome occur, such as agitation, hallucinations, fast heartbeat, fever, stiff muscles, tremor, diarrhea, or vomiting.
• Do not stop venlafaxine suddenly unless directed; the label recommends gradual dose reduction when possible.
• Tell your prescriber if you have high blood pressure, because venlafaxine can cause sustained increases in blood pressure and regular monitoring is recommended.
• Tell your prescriber if you have a history of narrow-angle eye problems, since antidepressant-related pupil dilation may trigger an angle-closure attack.
• Report sexual side effects if they occur, because the label notes decreased libido, delayed orgasm, erectile dysfunction, or delayed ejaculation can happen with SNRIs.
• Let your prescriber know if you notice anxiety, nervousness, insomnia, dizziness, nausea, sweating, or other symptoms after a dose change or stopping the medicine.
• Use caution with other serotonergic medicines or supplements, including certain antidepressants, triptans, tramadol, lithium, buspirone, fentanyl, methadone, meperidine, amphetamines, tryptophan, and St. John's Wort.

Helpful Patient Education

Venlafaxine tablets are a prescription antidepressant labeled for the treatment of major depressive disorder in adults. DailyMed labeling also describes important safety information, including warnings about suicidality, serotonin syndrome, blood pressure increases, discontinuation symptoms, and the need to avoid certain MAO inhibitor combinations.

This product page content is based on DailyMed label information and is intended to support general medication education. It is not a substitute for the full prescribing information or guidance from a health care professional.

Medication Summary last generated: 2026-07-12 03:09:55